Melanotan I dosage
Melanotan I is afamelanotide, a linear alpha-MSH analog that is more selective than MT-2 and does not cause the erections. As Scenesse it is a 16 mg implant placed every 2 months by a clinician. The 2004 Arizona tanning trials injected 0.08 to 0.16 mg/kg a day (5.6 to 11 mg for 70 kg) for 10 days, with only nausea and flushing. Community use of the 10 mg vials is far lower: 0.25 to 1 mg a day, then once or twice a week.
Basis: FDA label. Scenesse, subcutaneous implant placed above the hip by a trained clinician; erythropoietic protoporphyria only
- How often
- daily while loading (community) or 5 days a week (trial), then 1 to 2 times a week
- When
- evening; pair with modest sun exposure, which the trial showed it works with, not instead of
- How long
- 10 days to 4 weeks loading, maintenance through the season
- Route
- subcutaneous (vials); subcutaneous implant for the approved product
- Storage
- lyophilized: fridge or freezer; reconstituted: fridge, dark, use within 4 weeks (commonly reported)
Dose ranges by source
| Range | Per | Basis | Note |
|---|---|---|---|
| 16 mg implant every 2 months | 2 months | FDA label | Scenesse, subcutaneous implant placed above the hip by a trained clinician; erythropoietic protoporphyria only |
| 0.08 mg/kg to 0.16 mg/kg per day (5.6 mg to 11.2 mg at 70 kg) | day | clinical trial (Dorr et al. 2004, Arch Dermatol, three phase 1 studies, 10 days daily or 5 days a week for 4 weeks) | tanning in 3 of 4 subjects at the low dose; toxicity limited to nausea and transient facial flushing |
| 0.25 mg to 1 mg per day | day | commonly reported | loading, then 1 to 2 mg a week as maintenance |
Melanotan I dose to units chart
10 mg vial + 2 mL bacteriostatic water = 5 mg/mL (50 mcg per unit on a U-100 insulin syringe). 10 mg + 2 mL = 5 mg/mL, so 500 mcg = 0.1 mL = 10 units, 1 mg = 20 units and 250 mcg = 5 units.
| Dose | mL | Units (U-100) | Doses per vial |
|---|---|---|---|
| 11.2 mg | 2.24 | 224 | 0 |
| 16 mg | 3.2 | 320 | 0 |
| 20 mg | 4 | 400 | 0 |
Different vial or water? Full 10 mg + 2 mL table or set your own numbers below.
Side effects
- nausea
- transient facial flushing
- darkening of moles and freckles (the label calls for twice-yearly skin checks)
- appetite loss
- injection site redness
Melanotan I dosage questions
Melanotan 1 dosage for tanning?
Community practice is 0.25 to 1 mg a day for 10 days to 4 weeks with some sun, then 1 to 2 mg a week. The published tanning trials used 0.08 to 0.16 mg/kg a day for 10 days, about 10 times more, and saw only nausea and flushing. Start at 0.25 mg.
What is the difference between melanotan 1 and 2?
MT-1 is selective for the MC1 skin receptor, so it tans without the erections, strong appetite loss and most of the nausea that MT-2 causes. It needs more peptide per dose and works slower. MT-1 is also an approved drug (Scenesse) for a rare light-sensitivity disease; MT-2 is approved nowhere.
How many units is 1 mg of melanotan 1?
At 5 mg/mL (10 mg in 2 mL) 1 mg is 20 units. 500 mcg is 10 units. With 1 mL of water, halve those.
How long does melanotan 1 last?
The approved implant is replaced every 2 months. In the 2004 trial the tan held at least 3 weeks longer than sun alone. Users report the color fading over 1 to 2 months without maintenance doses.
Sources
- FDA prescribing information, SCENESSE (afamelanotide) implant, 2019
- Dorr RT et al., Arch Dermatol 2004, Effects of a superpotent melanotropic peptide (melanotan-1) in combination with solar UV radiation on tanning in human volunteers (PubMed 15262693)
- Peptide Protocol Wiki, Melanotan-1 dosing (community ranges)
Brands we recommend for Melanotan I. We are independent and have no affiliation with any brand: no affiliate links, no referral codes, no paid placements. These are the suppliers whose testing and certificates hold up when we check them.
- Licensed Peptides two accredited labs on every lot, certificates public, card and Apple Pay checkout
- Core Peptides long track record, public certificates, wide catalog
- Ascension Peptides public third-party testing, clear pricing
This page is an educational summary of published labels, trials and commonly reported use. It is not medical advice and does not replace a clinician.